CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 4 Conversion CEO & President acquired 25,000 shares (conversion)
- 4 Conversion Director acquired 25,000 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 424B3 Offering Prospectus
Page 3 of 82 · 1,636 filings